Cerebrospinal fluid complement activation in neurological diseases
- 1 February 1998
- journal article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 154 (2) , 173-181
- https://doi.org/10.1016/s0022-510x(97)00225-6
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Expression of complement in the brain: role in health and diseaseImmunology Today, 1996
- Increased concentration of C4d complement protein in CSF in amyotrophic lateral sclerosis.Journal of Neurology, Neurosurgery & Psychiatry, 1994
- Cerebrospinal fluid concentrations of the complement MAC inhibitor CD59 in multiple sclerosis and patients with other neurological disordersZeitschrift für Neurologie, 1994
- Elevation of human cerebrospinal fluid clusterin concentration is associated with acute neuropathologyJournal of the Neurological Sciences, 1993
- Multiple sclerosisJournal of the Neurological Sciences, 1992
- Diffuse CNS involvement in systemic lupus erythematosusNeurology, 1990
- Complement-activated oligodendroglia: A new pathogenic entity identified by immunostaining with antibodies to human complement proteins C3d and C4dNeuroscience Letters, 1990
- IMMUNOCYTOCHEMICAL LOCALIZATION OF THE TERMINAL COMPLEMENT COMPLEX IN MULTIPLE SCLEROSISNeuropathology and Applied Neurobiology, 1989
- New diagnostic criteria for multiple sclerosis: Guidelines for research protocolsAnnals of Neurology, 1983
- Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference valuesScandinavian Journal of Clinical and Laboratory Investigation, 1977